DK1417301T3 - Carbonhydrater og polyoler til oplösning af proteinkrystaller - Google Patents

Carbonhydrater og polyoler til oplösning af proteinkrystaller

Info

Publication number
DK1417301T3
DK1417301T3 DK02767141T DK02767141T DK1417301T3 DK 1417301 T3 DK1417301 T3 DK 1417301T3 DK 02767141 T DK02767141 T DK 02767141T DK 02767141 T DK02767141 T DK 02767141T DK 1417301 T3 DK1417301 T3 DK 1417301T3
Authority
DK
Denmark
Prior art keywords
carbohydrates
polyols
protein crystals
dissolving protein
dissolving
Prior art date
Application number
DK02767141T
Other languages
Danish (da)
English (en)
Inventor
Svend Kaasgaard
Kishore Rane
Michael Hess
Thomas Chambers Jr
Original Assignee
Novozymes As
Novozymes North America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23203804&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1417301(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novozymes As, Novozymes North America Inc filed Critical Novozymes As
Application granted granted Critical
Publication of DK1417301T3 publication Critical patent/DK1417301T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01001—Alpha-amylase (3.2.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01002—Beta-amylase (3.2.1.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK02767141T 2001-08-07 2002-08-06 Carbonhydrater og polyoler til oplösning af proteinkrystaller DK1417301T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31071701P 2001-08-07 2001-08-07
PCT/DK2002/000525 WO2003014339A2 (fr) 2001-08-07 2002-08-06 Hydrates de carbones et polyols permettant de dissoudre les cristaux de proteines

Publications (1)

Publication Number Publication Date
DK1417301T3 true DK1417301T3 (da) 2007-03-12

Family

ID=23203804

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02767141T DK1417301T3 (da) 2001-08-07 2002-08-06 Carbonhydrater og polyoler til oplösning af proteinkrystaller

Country Status (8)

Country Link
US (1) US20040175812A1 (fr)
EP (1) EP1417301B1 (fr)
CN (1) CN100494362C (fr)
AT (1) ATE344319T1 (fr)
AU (1) AU2002331306A1 (fr)
DE (1) DE60215823T2 (fr)
DK (1) DK1417301T3 (fr)
WO (1) WO2003014339A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE420161T1 (de) * 2002-07-01 2009-01-15 Novozymes As Monopropylenglykol als fermentationszusatz
WO2006136164A1 (fr) * 2005-06-24 2006-12-28 Novozymes A/S Cellules mutantes adaptees a la production de polypeptide recombinant

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1252610B (de) * 1964-01-08 1967-10-26 SINCOREP SA, Fnbourg (Schweiz) Verfahren zum Stabilisieren von Katalase
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
DE2512735A1 (de) * 1975-03-22 1976-09-30 Henkel & Cie Gmbh Verfahren zur gewinnung von proteinen aus waessrigen protein- loesungen
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
JPS5953038B2 (ja) * 1979-04-07 1984-12-22 メルシャン株式会社 サイクロデキストリンの製造法
US4588691A (en) * 1984-02-29 1986-05-13 Johal Sarjit S Method for preparation of Fraction I protein and by-products thereof
US4673647A (en) * 1985-05-06 1987-06-16 Miles Laboratories, Inc. Process to solubilize enzymes and an enzyme liquid product produced thereby
EP0410207B1 (fr) * 1989-07-24 1997-01-22 Bayer Corporation Stabilisation de protéines hautement purifiées
CA2120131A1 (fr) * 1991-09-27 1994-05-11 Robert A. Murgita Expression et purification d'alphafoetoproteine humaine clonee
US5443981A (en) * 1993-06-09 1995-08-22 Rutgers, The State University Acremonium typhinum ATCC 74228 which exhibits endoproteolytic activity
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste

Also Published As

Publication number Publication date
DE60215823T2 (de) 2007-09-06
EP1417301A2 (fr) 2004-05-12
AU2002331306A1 (en) 2003-02-24
EP1417301B1 (fr) 2006-11-02
WO2003014339A2 (fr) 2003-02-20
DE60215823D1 (de) 2006-12-14
US20040175812A1 (en) 2004-09-09
CN100494362C (zh) 2009-06-03
WO2003014339A3 (fr) 2003-06-05
ATE344319T1 (de) 2006-11-15
CN1539011A (zh) 2004-10-20

Similar Documents

Publication Publication Date Title
DE60027406D1 (de) Rückgewinnung eines proteins bei hohem ph-wert
DK0944617T3 (da) Krystaller af benzimidazolderivater og deres fremstilling
NO20013280L (no) Fluider og teknikker for komplettering av hydrokarbonbronner
EP1506211A4 (fr) C-aryl glucosides en tant qu'inhibiteurs de sglt-2 et methode correspondante
DK0606921T3 (da) Fremgangsmåde til isolering af Haemophilus influenzae protein E
FI952065A0 (fi) Foerfarande foer tillvaratagande av en kristalliserbar organisk foerening
DK0929547T3 (da) Benzamidinderivater substitueret af cykliske aminosyrederivater eller cykliske hydroxysyrederivater og deres anvendelse som antikoagulantia
YU48323B (sh) Postupak za dobijanje askorbinske kiseline
DK1569929T3 (da) Forbindelser og fremgangsmåder til behandling eller forebyggelse af flavi-virusinfektioner
DE60135842D1 (de) Wiederherstellung nach nervenschädigung
EP1561466A3 (fr) Sels d'acide boronique et leur utilisation dans la préparation de médicaments pour le traitement de la thrombose
DK0396069T3 (da) Salte af azelastin med forbedret opløselighed
ID30402A (id) Pengolahan kapur
PL1654284T3 (pl) Sposób uzyskiwania roztworu alfa-1-antytrypsyny
ATE344319T1 (de) Kohlhydrate und polyole zum lösen der proteinkristalle
DE60325731D1 (en) Monopropylenglykol als fermentationszusatz
DK0477198T3 (da) Fremgangsmåde til udvinding af rekombinante proteiner
ATE415470T1 (de) Herstellungsverfahren für iturin a und dessen homologe
DK1071692T3 (da) Fremgangsmåde til syntese af laminaribiose
ATE417117T1 (de) Verfahren zur herstellung von 2-keto-l-gulonsäure
NO20053592L (no) Vann opploslige fenylpyridazinderivater og medikamenter inneholdende disse.
DK1185551T3 (da) Fremgangsmåde til oprensning af proteiner
TWI265151B (en) Method of purifying niobium compound and/or tantalum compound
EP0882789A3 (fr) Procédé de synthese d'anhydrothrombine
WO2004009543A8 (fr) Composes